Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Moodys
Baxter
Boehringer Ingelheim
Merck

Get more done, faster

Accurate, objective, and timely intelligence to help you make better decisions


4.3/5 based on G2 reviews

4.4/5 based on Crozdesk reviews

Flexible Pricing Adapts to Your Needs


 

Free

Limited free access

$0

 
  • Limited searches each month
  • Some restrictions on platform functions
 

Limited

For low-volume use

Starting at $250

/ month
  • 35 searches per month
  • Includes all Modules
  • Daily Briefing Email Bulletin
  • Certificate Course on Branded Lifecycle Management and Generic Entry
  • Copy of Make Better Decisions book
MOST POPULAR 

Unlimited

Simple flat-rate access

$2,100

/ month

$19,250

/ year

    All Limited Plan Features, plus:

  • Data export to Excel or .csv file
  • Unlimited Searches
 

Enterprise

For teams

    All Unlimited Plan features, plus:

    • Multiple Users, or Company-Wide Access

Each plan includes the following modules


Pharmaceutical Drugs

  • US & International Patents
  • Active and Expired Patents in 134 Countries, Regulatory Protections and Exclusivities
  • Anticipate Generic Entry
  • Loss-of-Exclusivity Dates, Paragraph IV Challenges, Tentative Approvals, Authorized Generics, and more…
  • Find Commercial Opportunities
  • Single Source Off-Patent Drugs, Search Patents by Dosage Form / Therapeutic Class
  • Drug Sourcing
  • API, Finished Product Suppliers, First Generic Entrants

Biologic Drugs

  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Track Biosimilar Development
  • Finished Product Suppliers
  • Manufacturers

Excipients

  • Tie inactive ingredients to drug patents
  • Track drug patents based on their excipients
  • Identify clients for excipients
  • Find upcoming generic manufacturers needing your inactive ingredients

Investigational Drugs

  • Drug Candidates in Phase I-III Clinical Trials
  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Clinical Trial Progress
  • API Vendors

US Drug Patent Litigation

  • US District Court Cases
  • Patent Infringement, Contract Disputes, Antitrust, etc.
  • Patent Trial and Appeal Board
  • PTAB inter partes review, post-grant review

US Drug Prices

  • Brand vs. Generic Drug Price Gap
  • Find generic entry opportunities
  • Average Pharmacy Cost
  • Set reasonable launch prices
  • Best-Available Price
  • See price ranges

US Top Drug Sales

  • Annual Gross Revenues & Units Sold
  • Prescription Payment Methods
  • Self-Paid, Private Insurance, Medicaid, etc.
  • Pharmacy Locations & Types
  • Mail-order, Drugstore, in-Clinic, etc.

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

What our Clients Say

❝ I've been using DPW for years and I'm grateful for the responsiveness of the owner, Yali Friedman ❞

❝ I like best … the flexible subscription plans (by module, by month, by year, etc.) ❞

❝ My overall experience with DPW is very positive. The team is generally supportive and their features are growing over time. ❞

❝ Quick and easy to understand summaries, along with all the necessary links for further analysis. ❞

❝ Knowing when drugs are coming off patent and who to contract with has enabled us to stay ahead fo the curve and align ourselves with the proper vendors. ❞

❝ This is a great service with lots of insightful information. ❞

❝ I like the interface, and how it updates with news ❞

❝ Drugpatentwatch is an excellent opportunity for LATAM companies to access information on expired and protected patents from the USA and worldwide in a friendly and easy manner. ❞

❝ Found the results very comprehensive. The information told me who potential competitors are and what they are planning based on not only their NDAs and patents, but also references to clinical trials. ❞

❝ Information you don´t find anywhere else ❞

Clients in 74 Countries